Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015497
Filing Date
2023-04-28
Accepted
2023-04-28 08:46:43
Documents
4
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A def_proxy_2023.htm DEF 14A 1075499
2 GRAPHIC img116409514_0.jpg GRAPHIC 5549
3 GRAPHIC img116409514_1.jpg GRAPHIC 118115
4 GRAPHIC img116409514_2.jpg GRAPHIC 113016
  Complete submission text file 0000950170-23-015497.txt   1402916
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39527 | Film No.: 23860610
SIC: 2834 Pharmaceutical Preparations